Incidence of Intravascular (IV) Injection During Trigeminal Nerve Blocks

NCT ID: NCT04467398

Last Updated: 2023-08-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-20

Study Completion Date

2024-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the incidence of intravascular injection during trigeminal nerve blocks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The patients who already scheduled for trigeminal nerve blocks will be randomized in a 1:1 ratio to tuohy needle group or quincke needle group after being informed about the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Trigeminal Neuralgia Facial Pain Postherpetic Neuralgia Cluster Headache

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Tuohy needle group

The participants who undergo the trigeminal nerve block using 22 guage Tuohy needle.

trigeminal nerve block

Intervention Type PROCEDURE

Trigeminal nerve or branch block using 22 gauge Quincke or Tuohy needle under fluoroscopic guidance.

Quincke needle group

The participants who undergo the trigeminal nerve block using 22 guage Quincke needle.

trigeminal nerve block

Intervention Type PROCEDURE

Trigeminal nerve or branch block using 22 gauge Quincke or Tuohy needle under fluoroscopic guidance.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

trigeminal nerve block

Trigeminal nerve or branch block using 22 gauge Quincke or Tuohy needle under fluoroscopic guidance.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The patients who scheduled to undergo trigeminal nerve block due to the facial pain

Exclusion Criteria

* Refusal of the patient
* Pregnancy
* Coagulopathy
* Local or systemic infection
* Allergy to injectate
* Anatomical deformation of the skull
Minimum Eligible Age

19 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jeeyoun Moon

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul National University Hospital

Seoul, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jee Youn Moon, MD, PhD

Role: CONTACT

82220722952

Yongjae Yoo, MD, PhD

Role: CONTACT

82220722952

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jee Youn Moon, M.D.

Role: primary

82-10-5299-2036

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2004-207-1120

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.